{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:31:28Z","timestamp":1787776288509,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Despite advancements in the management of advanced ovarian, fallopian tube, and peritoneal cancers, there remains a need to explore safe and effective diagnostic techniques, particularly in cases where primary debulking surgery (PDS) is challenging. This retrospective study aimed to investigate the safety and availability of diagnostic laparoscopy for patients with advanced ovarian, fallopian tube, and peritoneal cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We analyzed data from 36 patients who underwent diagnostic laparoscopy between September 2017 and March 2023. The surgical outcomes of diagnostic laparoscopy and initial treatment outcomes were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median patient age was 65 years (range, 39\u201382 years), with majority diagnosed with high-grade serous carcinoma (HGSC). Perioperative complications were observed in 11% of patients. Neoadjuvant chemotherapy (NAC) was administered to 92% of patients, with PDS performed in two cases. Of the 33 patients who received NAC, 30 (90%) underwent interval debulking surgery, and 23 (77%) achieved complete resection. Two patients (clear-cell carcinoma and mucinous carcinoma) died of cancer before or during the initial chemotherapy. The median follow-up duration for all patients was 26.9 months. Median progression-free survival (PFS) was 19.7 months, and median overall survival was 65.5 months. In multivariate analysis, non-HGSC (hazard ratio: 3.20, 95% confidence interval [CI]: 1.07\u20139.61,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.038) and homologous recombination proficiency (hazard ratio: 7.44, 95% CI: 1.39\u201339.9,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.019) were risk factors for PFS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Diagnostic laparoscopy is useful for intraperitoneal observation and pretreatment diagnosis in advanced ovarian, fallopian tube, and peritoneal cancers. Despite tolerable perioperative complications, further research is warranted to optimize patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/gmit.gmit_32_24","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T05:08:09Z","timestamp":1743484089000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Laparoscopy for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancers: A Retrospective Study"],"prefix":"10.4103","volume":"14","author":[{"given":"Jongmyung","family":"Park","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Seike","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Sugi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Gondo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumu","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, St. Mary\u2019s Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"R2-20250522","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-20250522","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): An open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"R4-20250522","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.05.017","article-title":"Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group study JCOG0602","volume":"64","author":"Onda","year":"2016","journal-title":"Eur J Cancer"},{"key":"R5-20250522","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20250522","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"R7-20250522","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"R8-20250522","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N Engl J Med"},{"key":"R9-20250522","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa1909707","article-title":"Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med"},{"key":"R10-20250522","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1158\/1078-0432.CCR-22-3156","article-title":"Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes","volume":"29","author":"Pikkusaari","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R11-20250522","first-page":"CD005344","article-title":"Laparoscopy versus laparotomy for FIGO stage I ovarian cancer","volume":"10","author":"Falcetta","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20250522","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/gmit.gmit_99_22","article-title":"Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer","volume":"12","author":"Garcia","year":"2023","journal-title":"Gynecol Minim Invasive Ther"},{"key":"R13-20250522","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/GMIT.GMIT_59_18","article-title":"Is it the time for laparoscopic management of early-stage ovarian malignancies?","volume":"7","author":"Tantitamit","year":"2018","journal-title":"Gynecol Minim Invasive Ther"},{"key":"R14-20250522","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jmig.2016.01.029","article-title":"Laparoscopic management of ovarian cancer patients with localized carcinomatosis and lymph node metastases: Results of a retrospective multi-institutional series","volume":"23","author":"Gallotta","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R15-20250522","doi-asserted-by":"crossref","first-page":"113239","DOI":"10.18632\/oncotarget.22573","article-title":"Feasibility and outcome of primary laparoscopic cytoreductive surgery for advanced epithelial ovarian cancer: A comparison to laparotomic surgery in retrospective cohorts","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"R16-20250522","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s00464-017-5899-9","article-title":"Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: Prospective validation. \u201cThe times they are a-changin\u201d?","volume":"32","author":"Ceccaroni","year":"2018","journal-title":"Surg Endosc"},{"key":"R18-20250522","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: A randomized controlled trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J Clin Oncol"},{"key":"R19-20250522","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmig.2017.02.013","article-title":"Minimally invasive surgical staging in early-stage ovarian carcinoma: A systematic review and meta-analysis","volume":"24","author":"Bogani","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R20-20250522","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med"},{"key":"R21-20250522","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jmig.2017.04.024","article-title":"Epinephrine-induced takotsubo cardiomyopathy during laparoscopic myomectomy: Case report and review of the literature","volume":"24","author":"Nassif","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R22-20250522","first-page":"83","article-title":"Acute idiopathic heart failure following laparoscopic myotomy for achalasia of the esophagus","volume":"15","author":"Ural","year":"2015","journal-title":"Ochsner J"},{"key":"R23-20250522","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.21873\/invivo.12629","article-title":"Clinical availability of tumour biopsy using diagnostic laparoscopy for advanced ovarian cancer","volume":"35","author":"Odajima","year":"2021","journal-title":"In Vivo"},{"key":"R24-20250522","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"R25-20250522","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10147-011-0223-5","article-title":"Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery","volume":"16","author":"Hosono","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"R26-20250522","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2017.08.003","article-title":"Associations between residual disease and survival in epithelial ovarian cancer by histologic type","volume":"147","author":"Melamed","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R27-20250522","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R28-20250522","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00464-003-9233-3","article-title":"Fewer adhesions induced by laparoscopic surgery?","volume":"18","author":"Gutt","year":"2004","journal-title":"Surg Endosc"},{"key":"R29-20250522","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jog.13450","article-title":"2016 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009","volume":"43","author":"Saito","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"R30-20250522","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygyno.2022.12.009","article-title":"Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A memorial Sloan Kettering cancer center team ovary study","volume":"169","author":"Ehmann","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R31-20250522","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"R32-20250522","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"}],"container-title":["Gynecology and Minimally Invasive Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/gmit.gmit_32_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:01:54Z","timestamp":1787774514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/gmit.gmit_32_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/gmit.gmit_32_24","relation":{},"ISSN":["2213-3070","2213-3089"],"issn-type":[{"value":"2213-3070","type":"print"},{"value":"2213-3089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"2024-03-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}